Skip to main content
. Author manuscript; available in PMC: 2023 Jan 25.
Published in final edited form as: Nat Med. 2022 Apr 11;28(5):1022–1030. doi: 10.1038/s41591-022-01762-x

Fig. 3 ∣. Concentrations of post-product administration of AAV8-VRC07 plasma DNA.

Fig. 3 ∣

Longitudinal plasma AAV8-VRC07 DNA from 2 weeks after injection until two sequential longitudinal samples of less than 200 copies per milliliter of AAV8-VRC07 plasma DNA were found. Participants A–C received IM injections of 5 × 1010 vg kg−1 of AAV8-VRC07; Participants D and E received 5 × 1011 vg kg−1; and Participants F–H received 2.5 × 1012 vg kg−1.